For example, Pulakat et al. (2017) reported that chronic inhibition of mTOR by rapamycin reduced obesity and cardiac fibrosis in obese mice but increased blood glucose levels. Here, MTOR is linked to obesity due to melanocortin 4 receptor deficiency.